Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

5.65
Delayed Data
As of Aug 28
 +0.17 / +3.10%
Today’s Change
4.58
Today|||52-Week Range
10.26
-26.72%
Year-to-Date

Today’s Trading

Previous close5.48
Today’s open5.44
Day’s range5.43 - 5.66
Volume2,285,739
Average volume (3 months)2,546,673
Market cap$927.6M
Dividend yield10.62%
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.0
Price/Sales2.30
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.86+3.27%
ITCIIntra-Cellular Thera...+1.00+3.85%
FLMLFlamel Technologies ...-0.46-2.05%
SUPNSupernus Pharmaceuti...+0.28+1.60%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)$0.61
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Partner Offers